Zobrazeno 1 - 10
of 2 676
pro vyhledávání: '"M, Sandler"'
Autor:
Eric M Chung, Samuel C Zhang, Anthony T Nguyen, Katelyn M Atkins, Howard M Sandler, Mitchell Kamrava
Publikováno v:
Digital Health, Vol 9 (2023)
Objective Patients now have direct access to their radiology reports, which can include complex terminology and be difficult to understand. We assessed ChatGPT's ability to generate summarized MRI reports for patients with prostate cancer and evaluat
Externí odkaz:
https://doaj.org/article/df244481068749f7b1f5b2424952817c
Autor:
Mitchell Kamrava, Julie Jang, Emily Ko, Simon Knott, Tahir B Dar, Stephen L Shiao, Anthony T Nguyen, Jolene Viramontes, Satchel Stevens, Eric M Chung, Samuel Zhang, Katelyn M Atkins, Howard M Sandler, Jlenia Guarnerio, Zachary Zumsteg, David M Underhill
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/ff2179a1f4c745dca82f1dfc249ef9ac
Autor:
Andre Esteva, Jean Feng, Douwe van der Wal, Shih-Cheng Huang, Jeffry P. Simko, Sandy DeVries, Emmalyn Chen, Edward M. Schaeffer, Todd M. Morgan, Yilun Sun, Amirata Ghorbani, Nikhil Naik, Dhruv Nathawani, Richard Socher, Jeff M. Michalski, Mack Roach, Thomas M. Pisansky, Jedidiah M. Monson, Farah Naz, James Wallace, Michelle J. Ferguson, Jean-Paul Bahary, James Zou, Matthew Lungren, Serena Yeung, Ashley E. Ross, NRG Prostate Cancer AI Consortium, Howard M. Sandler, Phuoc T. Tran, Daniel E. Spratt, Stephanie Pugh, Felix Y. Feng, Osama Mohamad
Publikováno v:
npj Digital Medicine, Vol 5, Iss 1, Pp 1-8 (2022)
Abstract Prostate cancer is the most frequent cancer in men and a leading cause of cancer death. Determining a patient’s optimal therapy is a challenge, where oncologists must select a therapy with the highest likelihood of success and the lowest l
Externí odkaz:
https://doaj.org/article/54fe1e7fc7644b949b66c889805f2d44
Publikováno v:
Journal of Contemporary Brachytherapy, Vol 13, Iss 4, Pp 365-372 (2021)
Externí odkaz:
https://doaj.org/article/84097490aa1e45e6ba42d799b230a6b7
Autor:
Andre Esteva, Jean Feng, Douwe van der Wal, Shih-Cheng Huang, Jeffry P. Simko, Sandy DeVries, Emmalyn Chen, Edward M. Schaeffer, Todd M. Morgan, Yilun Sun, Amirata Ghorbani, Nikhil Naik, Dhruv Nathawani, Richard Socher, Jeff M. Michalski, Mack Roach, Thomas M. Pisansky, Jedidiah M. Monson, Farah Naz, James Wallace, Michelle J. Ferguson, Jean-Paul Bahary, James Zou, Matthew Lungren, Serena Yeung, Ashley E. Ross, NRG Prostate Cancer AI Consortium, Howard M. Sandler, Phuoc T. Tran, Daniel E. Spratt, Stephanie Pugh, Felix Y. Feng, Osama Mohamad
Publikováno v:
npj Digital Medicine, Vol 6, Iss 1, Pp 1-2 (2023)
Externí odkaz:
https://doaj.org/article/7d8e50289fd743a593f6ff3df5d018ef
Autor:
Jinbing Bai, Stephanie L. Pugh, Ronald Eldridge, Katherine A. Yeager, Qi Zhang, W. Robert Lee, Amit B. Shah, Ian S. Dayes, David P. D'Souza, Jeff M. Michalski, Jason A. Efstathiou, John M. Longo, Thomas M. Pisansky, Jordan M. Maier, Sergio L. Faria, Anand B. Desai, Samantha A. Seaward, Howard M. Sandler, Mary E. Cooley, Deborah W. Bruner
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 116:39-49
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::22c10d540b7f0e7a06deda8f64d1f698
https://doi.org/10.1016/j.ijrobp.2023.01.035
https://doi.org/10.1016/j.ijrobp.2023.01.035
Autor:
Rahul Khairnar, Stephanie L Pugh, Howard M Sandler, W Robert Lee, Ester Villalonga Olives, C Daniel Mullins, Francis B Palumbo, Deborah W Bruner, Fadia T Shaya, Soren M Bentzen, Amit B Shah, Shawn C Malone, Jeff M Michalski, Ian S Dayes, Samantha A Seaward, Michele Albert, Adam D Currey, Thomas M Pisansky, Yuhchyau Chen, Eric M Horwitz, Albert S DeNittis, Felix Y Feng, Mark V Mishra
Publikováno v:
PLoS ONE, Vol 16, Iss 4, p e0249123 (2021)
PurposeThe Expanded Prostate Cancer Index Composite (EPIC) is the most commonly used patient reported outcome (PRO) tool in prostate cancer (PC) clinical trials, but health utilities associated with the different health states assessed with this tool
Externí odkaz:
https://doaj.org/article/28c81274f9f04bb1953d4d523b5584d0
Autor:
Michael X. Henderson, Dustin J. Covell, Charlotte Hiu-Yan Chung, Rose M. Pitkin, Raizel M. Sandler, Samantha C. Decker, Dawn M. Riddle, Bin Zhang, Ronald J. Gathagan, Michael J. James, John Q. Trojanowski, Kurt R. Brunden, Virginia M.Y. Lee, Kelvin C. Luk
Publikováno v:
Neurobiology of Disease, Vol 136, Iss , Pp 104712- (2020)
Parkinson's disease (PD) and dementia with Lewy bodies (DLB) are progressive neurodegenerative diseases for which there is no disease-modifying treatment. PD and DLB are characterized by aggregation of the synaptic protein α-synuclein, and there is
Externí odkaz:
https://doaj.org/article/2065928935b24bed8f41f6623a293ece
Autor:
William A. Hall, Theodore G. Karrison, Seth A. Rosenthal, Mahul B. Amin, Leonard G. Gomella, James A. Purdy, A. Oliver Sartor, Jeff M. Michalski, Mark G. Garzotto, Carmen Bergom, Ashesh B. Jani, Colleen A.F. Lawton, Jeffry P. Simko, Joan K. Moore, Elizabeth M. Gore, W. Robert Lee, Paul L. Nguyen, Brita L. Danielson, Howard M. Sandler, Felix Y. Feng
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 114:266-274
The immunoinflammatory state has been shown to be associated with poor outcomes after radiation therapy (RT). We conducted an a priori designed validation study using serum specimens from Radiation Therapy Oncology Group (RTOG) 0521. It was hypothesi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73a0ec5fe63f1228fd468ece4ac47474
https://doi.org/10.1016/j.ijrobp.2022.05.048
https://doi.org/10.1016/j.ijrobp.2022.05.048
Autor:
William C. Jackson, Ming Tang, Matthew J. Schipper, Howard M. Sandler, Zachary S. Zumsteg, Jason A. Efstathiou, William U. Shipley, Wendy Seiferheld, Himanshu R. Lukka, Jean-Paul Bahary, Anthony L. Zietman, Thomas M. Pisansky, Kenneth L. Zeitzer, William A. Hall, Robert T. Dess, Richard D. Lovett, Alexander G. Balogh, Felix Y. Feng, Daniel E. Spratt
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 40(27)
PURPOSE Metastasis-free survival (MFS), but not event-free survival, is a validated surrogate end point for overall survival (OS) in men treated for localized prostate cancer. It remains unknown if this holds true in biochemically recurrent disease a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eeab4ef580c30a45c538da00ddfd7b61
https://pubmed.ncbi.nlm.nih.gov/35737923
https://pubmed.ncbi.nlm.nih.gov/35737923